To the full analysis
Gentherm stock: growth
THRMGentherm reported $1.5B in revenue for fiscal 2025, up 2.9% on the prior year, up 10.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
19.5%
per year from 2006 to 2025, per share 16.8%
Earnings (Annual rate)
9.1%
per year from 2006 to 2025, per share 6.9%
Free cash flow (Annual rate)
16.6%
per year from 2006 to 2025, per share 14%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 10.4% | 5.8% | 19.5% |
| Revenue per share | 11.9% | 7.5% | 16.8% |
| Earnings | −21.1% | −15.2% | 9.1% |
| Earnings per share | −20.0% | −13.8% | 6.9% |
| Free cash flow | −7.5% | 2.2% | 16.6% |
| Free cash flow per share | −6.3% | 3.9% | 14.0% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $50.61M | $3.51M | $3.3M |
| 2007 | $63.63M | $7.38M | $9.55M |
| 2008 | $63.61M | $3.56M | $3.18M |
| 2009 | $60.93M | $723K | $2.68M |
| 2010 | $112.4M | $9.95M | $10.58M |
| 2011 | $369.59M | $10.34M | $23.55M |
| 2012 | $554.98M | $17.87M | $10.41M |
| 2013 | $662.08M | $33.82M | $25.99M |
| 2014 | $811.3M | $70.12M | $41.45M |
| 2015 | $856.45M | $95.39M | $49.22M |
| 2016 | $917.6M | $76.6M | $42.08M |
| 2017 | $985.68M | $35.23M | −$905K |
| 2018 | $1.04B | $41.9M | $76.89M |
| 2019 | $971.68M | $37.51M | $95.07M |
| 2020 | $913.1M | $59.69M | $90.34M |
| 2021 | $1.05B | $93.43M | $97.05M |
| 2022 | $1.2B | $24.44M | −$25.25M |
| 2023 | $1.47B | $40.34M | $80.85M |
| 2024 | $1.46B | $64.95M | $36.33M |
| 2025 | $1.5B | $18.29M | $61.12M |
Revenue by segment
How Gentherm Incorporated makes its money and how that has shifted. Names are as the company reports them.
- Automotive97%
- Medical3%
- Other< 1%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|
| Automotive | $870M | $1B | $1.16B | $1.42B | $1.41B | $1.45B | 96.7% |
| Medical | $43.1M | $41.52M | no data | no data | $49.85M | $49.78M | 3.3% |
| Other | $0 | $0 | $43.04M | $46.12M | $0 | $0 | 0% |
| Total revenue | $913.1M | $1.05B | $1.2B | $1.47B | $1.46B | $1.5B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak since 12 Nov 2026, previously Neutral
- Valuation signal Fairly valued since 12 Nov 2026, previously Undervalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.